Cart
sales@molnova.com
Cetraxate HCl
CAS No. 27724-96-5
Cetraxate HCl( DV 1006 | DV-1006 | DV1006 | Cetraxate hydrochloride )
Catalog No. M24187 CAS No. 27724-96-5
Cetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 77 | In Stock |
|
| 100MG | 111 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 274 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCetraxate HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionCetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
-
DescriptionCetraxate HCl is an oral gastrointestinal medication. It has a cytoprotective effect.
-
In Vitro——
-
In Vivo——
-
SynonymsDV 1006 | DV-1006 | DV1006 | Cetraxate hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27724-96-5
-
Formula Weight341.83
-
Molecular FormulaC17H24ClNO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Oka M, Ichinose M, Fujishiro M, Omata M. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication]. Nihon Rinsho. 2005 Nov;63 Suppl 11:461-4. Japanese. PubMed PMID: 16363579.
molnova catalog
related products
-
Dilinoleyl Ketone
Dilinoleyl Ketone (Bis(linoleyl) ketone) is a lipid membrane that is a potential carrier of nucleic acids.
-
cGMP Dependent Kinas...
Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by PKG. Inhibits phosphorylation of intact histones by PKA.
-
Elgodipine
Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun.
